Rearrangements of anaplastic lymphoma kinase (ALK) are associated with several cancer diseases. Due to resistance development against existing ALK-inhibitors, new, structurally unrelated inhibitors are required. By a scaffold hopping strategy, 6,8-disubstituted purines were designed as analogues of similar ALK-inhibiting thieno[3,2-d]pyrimidines. While the new title compounds indeed inhibited ALK and several ALK mutants in submicromolar concentrations, they retained poor water solubility.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejpb.2017.03.011 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!